FLAD Treatment Results

Veterinary internists (DACVIM-SAIM) generally treat feline lower airway disease (FLAD; asthma + chronic bronchitis) as a chronic inflammatory airway disorder. The best long-term outcomes come from:

  1. daily suppression of airway inflammation,
  2. reduction of environmental irritants/triggers, and
  3. bronchodilators primarily for relief of bronchoconstriction (rescue; controller in select cases).

Which strategy most improves long-term symptom control?

Best overall long-term strategy (best risk–benefit, most consistent control):
Daily inhaled corticosteroid (maintenance) + environmental modification, with bronchodilator as rescue (and occasionally as a scheduled add-on in select cats with persistent bronchoconstriction).

How specialists would rank your options

1) Inhaled corticosteroids

Best long-term controller for most cats

  • In naturally occurring disease, fluticasone-based protocols can achieve clinical control. Small comparative studies suggest similar overall efficacy to oral glucocorticoids, with a more favorable long-term adverse-effect profile due to reduced systemic exposure.
  • Experimental and naturally occurring studies show inhaled steroids reduce airway inflammation markers (e.g., BAL eosinophilia) and improve measures of disease activity.

2) Combination inhaled steroid + bronchodilator

Helpful step-up adjunct; not the primary “controller” for most cats

  • Experimental acute asthma data suggest that adding a long-acting bronchodilator (e.g., salmeterol) to high-dose inhaled fluticasone can reduce eosinophilic inflammation more than fluticasone alone in that setting.
  • Clinically, internists typically use bronchodilators as rescue (albuterol/salbutamol). Scheduled bronchodilator add-ons are usually reserved for cats with ongoing bronchoconstriction despite adequate anti-inflammatory control.
  • Key clinical point: bronchodilators do not treat the underlying inflammation.

3) Oral corticosteroids

Very effective—often used for induction—but not ideal as the long-term default

  • Systemic glucocorticoids are reliably effective anti-inflammatories and are commonly used to stabilize patients, then transition to inhaled maintenance when feasible.
  • While small studies suggest oral and inhaled approaches may be similarly effective, long-term systemic risks (e.g., diabetogenic effects, skin fragility) push many specialists toward inhaled maintenance whenever possible.

4) Environmental modification alone

Essential supportive care, but rarely sufficient as sole long-term therapy

  • Trigger control (avoid smoke, dusty litter, aerosols, strong fragrances/cleaners) is standard-of-care and reduces flare frequency.
  • However, the feline literature more strongly supports glucocorticoid-centered anti-inflammatory control as the primary driver of sustained remission/control.

Specialist-style take-home

  • The biggest determinant of long-term control is consistent anti-inflammatory therapy:
    daily inhaled corticosteroid + trigger reduction + rescue bronchodilator for breakthrough signs.
  • Combination inhaled therapy (ICS + bronchodilator) becomes most valuable as a step-up strategy when bronchoconstriction persists despite adequate steroid control; experimental data supports synergy in some contexts, but bronchodilators remain supportive rather than foundational for long-term disease modification.

 

Works Cited (MLA)

Cohn, Leah A., et al. “Effects of Fluticasone Propionate Dosage in an Experimental Model of Feline Asthma.” Journal of Feline Medicine and Surgery, vol. 12, no. 2, 2010, pp. 91–96.

Galler, A., et al. “Inhaled Budesonide Therapy in Cats with Naturally Occurring Chronic Bronchial Disease (Feline Asthma and Chronic Bronchitis).” Journal of Small Animal Practice, vol. 54, no. 10, 2013, pp. 531–536. https://doi.org/10.1111/jsap.12133.

Leemans, Jérôme, et al. “Effect of Short-Term Oral and Inhaled Corticosteroids on Airway Inflammation and Responsiveness in a Feline Acute Asthma Model.” The Veterinary Journal, 2012, pp. 41–48. https://doi.org/10.1016/j.tvjl.2011.01.020.

Verschoor-Kirss, Michael, et al. “Treatment of Naturally Occurring Asthma with Inhaled Fluticasone or Oral Prednisolone: A Randomized Pilot Trial.” The Canadian Journal of Veterinary Research, vol. 85, no. 1, 2021, pp. 61–67.

Williams, Savannah Clare. “Do Inhaled or Oral Glucocorticoids More Effectively Control Feline Asthma?” Veterinary Evidence, vol. 7, no. 4, 2022. https://doi.org/10.18849/ve.v7i4.560.